Anzeige
Mehr »
Dienstag, 14.10.2025 - Börsentäglich über 12.000 News
Der Mann, der ein Lithium-Unternehmen im Wert von 1,2 Milliarden Dollar aufgebaut hat, ist zurück...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
224 Leser
Artikel bewerten:
(1)

BC Platforms Announces Colorado Center for Personalized Medicine Joins Global Data Partner Network BCRQUEST.com to advance Personalized Healthcare Research

ZURICH and BOSTON, Oct. 1, 2020 /PRNewswire/ -- BC Platforms, a global leader in clinical and genomic data management, analytics and access, today announced that it has formed a new data partnership with the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus that will incorporate clinical and genomic-consented records and biobank samples representing an ethnically diverse patient population from across the entire UCHealth system.

In October 2015, BC Platforms announced that it was supporting the launch of the CCPM by providing its personalized medicine platform, enabling it to develop a proprietary biobank, complementing existing tissue repositories and incorporating records from UCHealth's Electronic Medical Record system for large-scale genomic research to promote optimal clinical decision-making and personalized treatment for patients.

Five years later, CCPM is one of the largest health data warehouses in the United States with more than 8.7 million patient records, and a pioneer in driving large-scale personalized medicine efforts through a geno-pheno research biobank. CCPM's significant advancements in making pharmacogenomics a standard of care are already providing benefits, and with plans to expand the provision of personalized healthcare, patients will soon have access to more clinically-actionable results.

Kathleen Barnes, PhD, professor and director of CCPM, commented, "We've been using BC Platforms' personalized medicine platform for many years. We're so appreciative that BCP has proven themselves to be an eager and willing CCPM partner, and we're delighted to add this data partnership to our strategic collaboration. By being able to efficiently engage with drug developers, innovative organizations such as ours can enable discoveries on new ways to treat diseases."

Jennifer Cubino, Executive Vice President, Head of Data Science at BC Platforms, commented, "Our global footprint of the Global Data Partner Network BCRQUEST.com is rapidly growing as organisations recognise the value of expertly curated, and carefully governed, patient data in forging research partnerships. We encourage health systems to invest in consenting and data infrastructure as it provides strong foundations underpinning personalised medicine and ultimately improve outcomes for patients. We are delighted to welcome the University of Colorado Anschutz Medical Campus, a prestigious USA medical research site driving forward personalised medicine, to our coalition of data pioneers, enabling discovery with the power of a global network."

About BC Platforms

BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice. Our technology drives the infinite loop between personalized care and research discoveries, leveraging latest science, deep technical expertise, strategic partnerships, and harmonized, diverse data collections. Our high performing platforms enable high throughput genomic data production, flexible data integration, secure data management, efficient analysis and interpretation of molecular and clinical information.

BC Platforms has developed the Global Data Partner Network BCRQUEST.com, which provides access and analytics on genomic and clinical cohort data for drug developers.

Founded in 1997 from an MIT Whitehead project spinoff, the Company has a strong scientific heritage underpinned by over 20 years of working in close collaboration with a network of leading researchers, developers, manufacturers and vendors. BC Platforms has global operations with its headquarters in Zurich, Switzerland, research and development in Espoo, Finland, and sales and marketing in Boston, USA, London, UK and Singapore. For more information, please visit www.bcplatforms.com or follow us on Linkedin BC Platforms.

About the University of Colorado Anschutz Medical Campus

The University of Colorado Anschutz Medical Campus is a world-class medical destination at the forefront of transformative science, medicine, education, and patient care. The campus encompasses the University of Colorado health professional schools, more than 60 centers and institutes, and two nationally ranked independent hospitals that treat more than two million adult and pediatric patients each year. Innovative, interconnected and highly collaborative, together we deliver life-changing treatments, patient care, professional training, and conduct world-renowned research. For more information, visit www.cuanschutz.edu.

Contact information:

BC Platforms:
Tero Silvola
BC Platforms AG
tero.silvola@bcplatforms.com

Katja Stout
Scius Communications
katja@sciuscommunications.com

Kelsea Pieters
University of Colorado Anschutz Medical Campus
kelsea.pieters@cuanschutz.edu

© 2020 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.